• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Bricalin Turbuhaler
    / Teva


    Active Ingredient
    Terbutaline Sulphate 0.5 mg/dose

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Metered Dose Inhaler

    100 doses

    full basket chart 20929

    Metered Dose Inhaler

    200 doses

    full basket chart 2373

    Dosage

    Note: Bricalin Turbuhaler should be stored with the cover tightened.
    Bricalin Turbuhaler should be administered to children, only under adult supervision.
    The usual dosage for adults and children is 1 inhalation repeated every 6 hours. Dosing: should not be repeated more often than every 4 to 6 hours.
    The use of Bricalin Turbuhaler can be continued as medically indicated to control recurring bouts of bronchospasm.


    Indications

    Relief of bronchospasm in asthma, chronic bronchitis, emphysema.


    Contra-Indications

    Bricalin preparations are contraindicated in patients with a history of sensitivity to terbutaline sulphate or to any other ingredient of the preparations.
    Tocolysis: Oral terbutaline sulfate is contraindicated for the treatment of acute or maintenance tocolysis.


    Special Precautions

    Pregnancy and lactation. Should not be used for women in labor. Patients with cardiovascular disorders, hyperthyroidism or diabetes mellitus, a history of seizures, or in patients who are unusually responsive to sympathomimetic amines. Patients susceptible to hypokalemia should be monitored. Additional blood glucose tests are recommended for asthmatic patients with concomitant diabetes.
    See prescribing information for full details.


    Side Effects

    Tremor and nervousness, headache, increased heart rate, palpitations, increased blood pressure, drowsiness, nausea, vomiting and sweating. Like other sympathomimetic agents, terbutaline can cause adverse reactions such as angina, dyspnea and wheezing, vertigo, central stimulation, insomnia and unusual taste.
    See prescribing information for full details.


    Drug interactions

    Beta-blocking agents (including eye drops), especially the non-selective ones such as propranolol, may partially or totally inhibit the effect of beta-stimulants. Therefore, Bricalin preparations and non-selective beta-blockers should not normally be administered concurrently. Bricalin should be used with caution in patients receiving other sympathomimetics.
    Hypokalemia may result from beta2-agonist therapy and may be potentiated by concomitant treatment with xanthine derivatives, corticosteroids and diuretics.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    CLOSE